BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9209416)

  • 1. Regulation of megakaryocytopoiesis by thrombopoietin and stromal cells.
    Nagata Y; Nagahisa H; Nagasawa T; Todokoro K
    Leukemia; 1997 Apr; 11 Suppl 3():435-8. PubMed ID: 9209416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin and its receptor.
    Wendling F; Vainchenker W
    Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
    Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
    Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase.
    Drayer AL; Boer AK; Los EL; Esselink MT; Vellenga E
    Stem Cells; 2005 Feb; 23(2):240-51. PubMed ID: 15671147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin signal transduction: studies from cell lines and primary cells.
    Drachman JG; Rojnuckarin P; Kaushansky K
    Methods; 1999 Mar; 17(3):238-49. PubMed ID: 10080909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
    Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
    Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
    Tong W; Lodish HF
    J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist.
    Erickson-Miller CL; DeLorme E; Tian SS; Hopson CB; Stark K; Giampa L; Valoret EI; Duffy KJ; Luengo JL; Rosen J; Miller SG; Dillon SB; Lamb P
    Exp Hematol; 2005 Jan; 33(1):85-93. PubMed ID: 15661401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
    Quentmeier H; Zaborski M; Drexler HG
    Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3.
    Bacon CM; Tortolani PJ; Shimosaka A; Rees RC; Longo DL; O'Shea JJ
    FEBS Lett; 1995 Aug; 370(1-2):63-8. PubMed ID: 7544303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation.
    Nagahisa H; Nagata Y; Ohnuki T; Osada M; Nagasawa T; Abe T; Todokoro K
    Blood; 1996 Feb; 87(4):1309-16. PubMed ID: 8608219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin induces tyrosine phosphorylation of a common beta subunit of GM-CSF receptor and its association with Stat5 in TF-1/TPO cells.
    Ooi J; Tojo A; Asano S; Sato Y; Oka Y
    Biochem Biophys Res Commun; 1998 May; 246(1):132-6. PubMed ID: 9600081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin induces activation of at least two distinct signaling pathways.
    Nagata Y; Todokoro K
    FEBS Lett; 1995 Dec; 377(3):497-501. PubMed ID: 8549784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
    Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I
    EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
    Piekorz RP; Hocke GM
    Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
    Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y
    Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells.
    Gallmeier E; Schäfer C; Moubarak P; Tietz A; Plössl I; Huss R; Göke B; Wagner AC
    J Cell Physiol; 2005 Apr; 203(1):209-16. PubMed ID: 15493010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel MPL point mutation resulting in thrombopoietin-independent activation.
    Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
    Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.
    Kalina U; Koschmieder S; Hofmann WK; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
    Exp Hematol; 2001 May; 29(5):602-8. PubMed ID: 11376873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.
    Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y
    Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.